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Palatal myoclonusAbstract Patients with palatal myoclonus may suffer from pulsatile tinnitus stemming from invol-
untary contractions of tensor veli palatini and levator veli palatini muscles. Botulinum toxin (BTX)
injection to these muscles is effective in resolving pulsatile tinnitus symptom. We present a case of
pulsatile tinnitus who was effectively treated with BTX injection under an electromyography guid-
ance as an office procedure.
 2016 Egyptian Society of Ear, Nose, Throat and Allied Sciences. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Palatal myoclonus (PM) is a rare cause of objective tinnitus,
first described in 1878 by Politzer.1 It is a rhythmic and invol-
untary movements of soft palatal muscles that is also defined
as palatal tremor by many authors.2 PM consists of two dis-
tinct clinical forms called symptomatic and essential. Symp-
tomatic PM is thought to arise as a result of brainstem or
cerebellar lesions involved the dentato-rubro-olivary pathway
in the triangle of Guillain-Mollaret. The levator veli palatine
muscle is mostly affected.3,4 Although, there is no focal neuro-
logical lesions associated with essential PM detected on imag-
ing.5,6 EPM usually affects the tensor veli palatini muscle.Tinnitus is generated by involuntary rhythmic contraction of
tensor veli palatini and levator veli palatini muscles being
source of an audible click. We herein present an objective tin-
nitus case who received BTX injections into the palatal area
using electromyographic guidance for the treatment of EPM.
2. Case report
A 23-year-old woman complained of involuntary movements
of palate and tinnitus in her left ear for the past four months.
She denied any of the associated symptoms including hearing
loss, vertigo, otalgia or prior otologic surgeries, otitis media
and acoustic trauma. She had no history of systemic disease.
She received a medical treatment for a month to alleviate her
tinnitus, no relief obtained though. A brain magnetic reso-
nance imaging and neurologic examination were completely
normal. There were no abnormal findings on otoscopic
Figure 2 Unilateral injection of BTX into the tensor veli palatini
and levator veli palatini muscle.
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getting approximately 5 cm close to her left ear. Also, we have
seen rhythmic contractions of the soft palate roughly at a rate
of 100 movements per minute. A pure tone audiogram and
tympanogram presented normal hearing and impedance bilat-
erally. Tinnitus was masked by a white noise at 3 kHz and
67 dB. Patient was diagnosed as EPM. An electromyogram
recorded regular bursts of electrical activity at firing rate 5
per 3 s (Fig. 1). We injected 2.5 U BTX type A either into
the tensor veli palatini and levator veli palatini muscle
unilaterally under an electromyographic guidance (Fig. 2). A
monopolar, EMG recording needle is a 27 gauge and Teflon
coated. The BTX was loaded into a tuberculin syringe that
was attached to a EMG needle. Then, appropriate BTX type
A dose was delivered into the palatal area while observing
maximal electrical activity. The patient tolerated BTX injec-
tions well, without the need of local anesthetic and no side
effects were observed. Tinnitus in her left ear decreased on
the third day. The patient achieved complete relief of tinnitus
and no involuntary movements of soft palate after two weeks.
She had symptomatic relief for 4 months and then we observed
a slight contraction of the left soft palate with associated tinni-
tus. We decided to apply a second dose of BTX type A.
3. Discussion
Essential PM is a rare cause of objective tinnitus considered to
generate by involuntary movements of soft palate. The symp-
toms which can be seen in a wide age range including
childhood onset, have been experienced mostly in middle age
patients.7 Spontaneous remission may occur occasionally,
but most of the patients need specific therapy.8 Essential PM
usually affects the tensor veli palatini and levator veli palatini
as well as the other soft palate and pharynx musculature
including salpingopharyngeus, palatopharyngeus and superior
pharyngeal constrictor that sometimes take a part in the clinic.
Although, different treatment options have been defined
including medical, and surgical, general response to these
approaches is commonly poor.9 Similarly, surgical procedures
have not widely gained any success in the treatment of EPM.
Most of the objective tinnitus cases resulting from PM,
experienced complete resolution of symptoms after 1 or 2
BTX injections. To our knowledge BTX injections has been
performed at a dose range between 2.5 U to 30 U for palatal
myoclonus treatment in the literature.7,8,10 We injected the
minimum effective dose of 2.5 U BTX described in the litera-
ture so as to limit the possible side effects.3,5,7 Injections eitherFigure 1 Electromyographic pattern composed of five rhythmic
bursts.to the tensor veli palatini muscle or levator veli palatini muscle
have been suggested to subside the symptoms of tinnitus and
palatal movement respectively.
The average symptom free period is between 2 to 6 months
in literature.5 In our case she achieved symptomatic relief for
about four months and no side effects were observed with min-
imum dose described in the literature. Due to using an elec-
tromyographical guidance, we could perform the minimum
dose for symptomatic relief.
4. Conclusion
Botulinum toxin injection can be used in the first line treat-
ment for objective tinnitus from palatal myoclonus patients.
BTX is safe and effective but, because of temporary effect of
the toxin, we need repeated injections about every 5–6 months.
We suggest that BTX injection must be done under an elec-
tromyographic guidance in order to use minimum dose for
symptomatic relief and avoid side effects. Using an elec-
tromyographic guidance more effectivity can be provided with
a lower dosage.
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